Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Database | Last Updated |
---|---|
ChEBI | February 3, 2022 |
KEGG | February 3, 2022 |
LIPID MAPS Structure Database | February 3, 2022 |
LipidBank | February 3, 2022 |
PubChem | February 3, 2022 |
Main Class | Sub Class | LM ID | Common Name ▼ | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II H antigen(d18:1/16:0)
|
1737.940052
|
C80H143N3O37
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II H antigen
|
GSG1175
|
||||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/26:1(17Z))
|
1673.001528
|
C82H148N2O32
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/26:1(17Z))
|
2038.133727
|
C96H171N3O42
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/26:0)
|
1675.017178
|
C82H150N2O32
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/26:0)
|
2040.149377
|
C96H173N3O42
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/24:1(15Z))
|
1644.970228
|
C80H144N2O32
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/24:1(15Z))
|
2010.102427
|
C94H167N3O42
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/24:0)
|
1646.985878
|
C80H146N2O32
|
|||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II B antigen(d18:1/24:0)
|
2012.118077
|
C94H169N3O42
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01